A Study Of Avelumab In Combination With Axitinib In Advanced Renal Cell Cancer (JAVELIN Renal 100)

NCT02493751 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

55

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Cell Cancer

Interventions

DRUG: Avelumab (MSB0010718C)
DRUG: Axitinib (AG-013736)

Sponsor

Pfizer